First Horizon Corporation’s Integra LifeSciences IART Stock Holding History

First Horizon Corporation’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.96K	Buy	+109	New	+$1.52K	﹤0.01%	1354
2021 Q2	$0	Hold	7	–	–	﹤0.01%	1128
2021 Q1	$0	Hold	7	–	–	﹤0.01%	1118
2020 Q4	$0	Hold	7	–	–	﹤0.01%	1134
2020 Q3	$0	Buy	+7	New	+$333	﹤0.01%	1087
2013 Q2	$16K	Buy	+1,101	New	+$16.1K	﹤0.01%	419

Other funds holding IART

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

First Horizon Corporation's IART Position: Q2 2026 in Review

First Horizon Corporation opened a new position in Integra LifeSciences (IART) in Q2 2026: 109 shares worth $1.96K. The stake represents ﹤0.01% of the portfolio and ranks #1354 among its holdings. This is a return to the name: First Horizon Corporation previously reported a position in IART as recently as Q2 2021.

First Horizon Corporation first reported a position in IART in Q2 2013 and has held it in 6 quarters since. The position peaked at $16K in Q2 2013. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

First Horizon Corporation held 109 shares of Integra LifeSciences worth $1.96K as of Q2 2026.
Integra LifeSciences was a new First Horizon Corporation position in Q2 2026.
Integra LifeSciences made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2026, its #1354 holding.
First Horizon Corporation first reported a position in Integra LifeSciences in Q2 2013 and has held it in 6 quarters since.
First Horizon Corporation's Integra LifeSciences position peaked at $16K in Q2 2013.
212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.